London, United Kingdom

Marc Feldmann

USPTO Granted Patents = 20 

 

Average Co-Inventor Count = 2.8

ph-index = 7

Forward Citations = 112(Granted Patents)


Location History:

  • Hammersmith, GB (1997 - 1999)
  • London, GB (1999 - 2023)

Company Filing History:


Years Active: 1997-2025

Loading Chart...
Loading Chart...
20 patents (USPTO):Explore Patents

Title: The Innovations of Inventor Marc Feldmann

Introduction

Marc Feldmann is a prominent inventor based in London, GB, known for his significant contributions to medical science with a total of 18 patents to his name. His research primarily focuses on treatments related to fibrotic disorders and innovative methodologies that improve patient outcomes.

Latest Patents

Among his latest innovations are two notable patents that address serious medical conditions. The first is a patent for a method of treating Dupuytren's disease using a pre-filled syringe. This invention provides a method whereby individuals afflicted with early-stage Dupuytren's disease—characterized by the presence of nodules on the hand—can receive treatment through an injection of a pharmaceutical composition containing an antihuman TNFa antibody. The composition is delivered in a liquid form, with specific dosages of 0.1 ml to 0.6 ml injected into each nodule. Additionally, this patent includes the design of a pre-filled syringe to facilitate this method of treatment.

The second recent patent focuses on a method of treating localized fibrotic disorders utilizing an IL-33 antagonist. It outlines a treatment protocol for patients suffering from localized fibrotic conditions, administering an effective amount of an IL-33 antagonist or a TNF receptor 2 (TNFR2) antagonist to achieve therapeutic benefits.

Career Highlights

Marc Feldmann has made substantial strides in the medical field through his work at esteemed institutions such as the Mathilda and Terence Kennedy Institute of Rheumatology Trust and the Mathilda and Terence Kennedy Institute of Rheumatology. Through his career, he has developed innovative therapeutic approaches that have the potential to transform treatment paradigms for various fibrotic diseases.

Collaborations

Throughout his career, Feldmann has collaborated with notable colleagues, including Ravinder Nath Maini and Jagdeep Nanchahal. Their joint efforts have contributed to advancing research and development in rheumatology, focusing on improving patient health through groundbreaking inventions.

Conclusion

Marc Feldmann's dedication to innovation in medical science, underscored by his 18 patents, positions him as a pivotal figure in the treatment of fibrotic diseases. His recent innovations promise to enhance therapeutic options for patients, showcasing the impact that inventive minds like his can have on healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…